SEATTLE, WA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CANCER RESEARCH AND BIOSTATISTICS, founded in 1997, is a mid-sized nonprofit in the Medical Research sector that reported $12.1M in total revenue in fiscal year 2023.
CANCER RESEARCH AND BIOSTATISTICS (CRAB) IS A NON-PROFIT ORGANIZATION WHOSE PURPOSE IS TO HELP CONQUER CANCER AND OTHER DISEASES THROUGH THE APPLICATION OF BIOSTATISTICAL PRINCIPLES AND INNOVATIVE DATA MANAGEMENT METHODS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $12,083,341 | $12,214,852 | 0.0% |
| Expenses | $12,527,849 | $12,123,661 | +0.0% |
| Net Income | $-444,508 | $91,191 | -5.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HOERING ANTJE | CEO & BOARD PRESIDENT | 40.00 |
Officer
Director
|
$378,488 | $38,308 | $416,796 |
| CROWLEY JOHN J | DIRECTOR/CHIEF OF STRATEGIC ALLIANCES | 16.00 |
Director
|
$84,840 | $0 | $84,840 |
| DAVIS RODERIC | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| HEAGERTY PATRICK | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| CURCI FRANK | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| GOODMAN GARY | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| GRAY DAVID | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| LEBLANC MICHAEL | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| CUMMINS TIM | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| SNAPINN STEVE | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| ALVENDIA MELISSA | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| ROSS ARTHUR | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| SHAM JONATHAN | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| MALLOY CURT | VP, COO & BOARD SECRETARY | 40.00 |
Officer
|
$221,445 | $28,014 | $249,459 |
| COOK CHRIS | VP, CHIEF TECHNOLOGY OFFICER | 40.00 |
Officer
|
$198,488 | $23,618 | $222,106 |
| MAR CHONG DAMIEN | VP, CFO & BOARD TREASURER | 40.00 |
Officer
|
$184,799 | $22,944 | $207,743 |
| DURHAM PATRICK G | DIRECTOR OF IT | 40.00 |
Highest
|
$174,103 | $22,034 | $196,137 |
| NISHIMURA KATHERINE K | SENIOR BIOSTATISTICIAN | 40.00 |
Highest
|
$172,007 | $21,152 | $193,159 |
| MILLER BRIAN | DIRECTOR OF FINANCE | 40.00 |
Highest
|
$166,668 | $17,995 | $184,663 |
| SUTTER RODNEY | PROGRAM DIRECTOR, THERAPEUTIC STUDIES | 40.00 |
Highest
|
$141,166 | $19,773 | $160,939 |
| BARLOW WILLIAM E | SENIOR BIOSTATISTICIAN | 24.00 |
Highest
|
$144,217 | $19,231 | $163,448 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $12,083,341 | $12,527,849 | $11,524,760 | $-444,508 |
| 2022 | $12,214,852 | $12,123,661 | $12,381,610 | $91,191 |
| 2021 | $11,626,712 | $11,787,377 | $8,442,496 | $-160,665 |
| 2020 | $12,617,095 | $11,280,432 | $8,761,603 | $1,336,663 |
| 2019 | $12,787,003 | $12,197,319 | $7,388,278 | $589,684 |
| 2018 | $13,151,469 | $12,750,418 | $7,935,812 | $401,051 |
Compare CANCER RESEARCH AND BIOSTATISTICS with other nonprofits in Washington and across the country.